(Reuters) – Expansion services provider DKSH reported an annual core operating profit in line with market expectations on Wednesday, with its healthcare unit making up the lion’s share of its business.
Its core earnings before interest and taxes (EBIT) were 343.1 million Swiss francs ($365.76 million) in 2024, broadly in line with analysts’ forecast of 344.3 million francs, according to a Vara Research poll.
For 2025, the Zurich-based firm expects the core earnings to be higher than last year, without giving a concrete figure.
“The group remains confident about Asia Pacific’s long-term potential and is well-positioned to benefit from favorable market, industry, and M&A consolidation trends,” it said in a statement.
DKSH makes roughly 70% of its sales in South East Asia, a region of growing importance as some companies seek to shift their production away from China to avoid a hit from geopolitical spats.
($1 = 0.9129 Swiss francs)
(Reporting by Isabel Demetz and Paolo Laudani in Gdansk; Editing by Milla Nissi)
